India’s pharmaceutical sector witnessed a steady flow of capital deployment, strategic investments, and funding-led expansion between March 30 and April 9, 2026, driven by global acquisition ambitions, domestic capacity building...
The C4 Therapeutics & Roche cancer deal has taken a major step forward as both companies expand their partnership in a move that could exceed USD 1 billion. The updated agreement strengthens their focus on developing new cancer treatments using...
India’s vaccine testing shift to govt labs only is making waves today, with the Centre moving to restrict testing of vaccines and biological products to government facilities. The proposed shift in vaccine testing aims to tighten oversight...
The Lupin Human Welfare & Research Foundation has taken another important step to improve healthcare access in Rajasthan by introducing new diagnostic facilities focused on non-communicable diseases (NCDs). This initiative aims to make earl...
India’s pharmaceutical industry is likely to see pressure on its earnings from the US market in the coming quarter, even though domestic growth remains strong, according to a report by Nuvama Institutional Equities.
India is moving quickly to secure methanol supply for pharma as West Asia crisis begin to strain imports of this key raw material. The methanol supply for pharma sector has come under pressure due to geopolitical tensions affecting...
India is moving ahead with a digital portal to track narcotic drugs, a step aimed at tightening oversight on controlled medicines.The proposed digital portal to track narcotic drugs will create a centralized system to monitor the movement and use...
In an increasingly digital-first healthcare environment, more patients are turning to online searches, home remedies, and AI-driven tools to self-diagnose and make treatment decisions. A trend Paras Health flagged on World Health Day as a key...
In a major move, Redcliffe Labs divests Crysta IVF to Moon Care, the healthcare arm of MMG Group, reinforcing its focus on diagnostics. This Redcliffe Labs divests Crysta IVF deal highlights the company’s preventive-first strategy and sharper...
A Parliamentary panel has recommended major changes to how traditional medicine drugs are regulated in India, calling for the creation of a single, independent authority to oversee the Ayush sector regulation.
.jpg)
.jpg)
, CDSCO.jpg "Fostering a Quality Culture in the Pharmaceutical Industry")